COVID-19: Implications for ART Management

COVID-19: Implications for Managing Antiretroviral Therapy in Patients With HIV

In this collection of commentaries, expert faculty review the guidance and provide expert perspective on how to manage ART in patients with HIV during the COVID-19 pandemic; topics include maintaining stable ART, COVID-19 risk in persons with HIV, and switching ART.

Princy N. Kumar, MD, FIDSA, MACP

Paul E. Sax, MD

ClinicalThought

COVID-19 Risk in Patients With HIV: Implications for ART Management

View ClinicalThought

The DHHS released interim guidance on special considerations during the COVID-19 pandemic for patients with HIV. Here’s my take on how these can be incorporated into practice to minimize patient risk.

Paul E. Sax, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Released: April 10, 2020 Expired: April 9, 2021

ClinicalThought

Ensuring Uninterrupted ART for Patients With HIV During the COVID-19 Pandemic

View ClinicalThought

The DHHS recently released practical guidance on maintaining stable ART for patients with HIV during the COVID-19 pandemic. Here are some considerations for implementing this guidance.

Princy N. Kumar, MD, FIDSA, MACP Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Released: April 21, 2020 Expired: April 20, 2021

COVID-19: Implications for Managing Antiretroviral Therapy in Patients With HIV

ClinicalThought

COVID-19 Risk in Patients With HIV: Implications for ART Management

Ensuring Uninterrupted ART for Patients With HIV During the COVID-19 Pandemic

Leaving the CCO site